Clinical Outcomes of Double Staining and Additional ILM Peeling during ERM Surgery.
10.3341/kjo.2013.27.4.256
- Author:
Ha Na OH
1
;
Joo Eun LEE
;
Hyun Woong KIM
;
Il Han YUN
Author Information
1. Department of Ophthalmology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea. ihyun@inje.ac.kr
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
Double staining;
Epiretinal membrane;
Internal limiting membrane
- MeSH:
Aged;
Coloring Agents/diagnostic use;
Epiretinal Membrane/*surgery;
Female;
Follow-Up Studies;
Humans;
Indocyanine Green/*diagnostic use;
Male;
Middle Aged;
Postoperative Complications/*diagnosis;
Retinal Hemorrhage/diagnosis;
Retrospective Studies;
Treatment Outcome;
Visual Acuity;
*Vitrectomy
- From:Korean Journal of Ophthalmology
2013;27(4):256-260
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: To assess the clinical outcomes in idiopathic epiretinal membrane (ERM) patients after vitrectomy and ERM removal with or without additional indocyanine green (ICG)-assisted internal limiting membrane (ILM) peeling. METHODS: The medical records of 43 patients with an idiopathic ERM that underwent vitrectomy and ERM removal between July 2007 and April 2010 were reviewed. The patients were divided into two groups: triamcinolone-assisted simple ERM peeling only (group A, n = 23) and triamcinolone-assisted ERM peeling followed by ICG staining and peeling of the remaining internal ILM (group B, n = 20). RESULTS: No difference was found between the two groups in terms of visual acuity, macular thickness, P1 amplitude or implicit time on multifocal-electroretinogram (mfERG) at six and 12 months postoperatively. In group B, ICG staining after ERM peeling demonstrated that the ILM had been removed together with the ERM in 12 eyes (60%), and all 12 eyes showed punctate retinal hemorrhages during ERM peeling. There was no recurrence of an ERM in either group. CONCLUSIONS: Additional procedures involving ICG staining and ILM peeling during ERM surgery do not appear to have an additive effect on the clinical outcomes in terms of visual acuity, retinal function based on mfERG, or recurrence rate.
